doi: 10.1007/BF01949891.
Glycogenolytic effect of vasoactive intestinal peptide in the rat in vivo
Affiliations
- PMID: 2065763
- DOI: 10.1007/BF01949891
Item in Clipboard
Glycogenolytic effect of vasoactive intestinal peptide in the rat in vivo
Experientia.
.
Abstract
The effects of VIP (300 pmol/kg), injected via the portal vein, on the glycogen content of the liver and on glycemia, were studied in the rat in vivo. VIP enhanced glycogenolysis and caused hyperglycemia in a time-dependent manner.
Similar articles
-
Stimulatory effect of vasoactive intestinal peptide on glycogenolysis and gluconeogenesis in isolated rat hepatocytes: antagonism by insulin.Endocrinology. 1983 Jun;112(6):2120-7. doi: 10.1210/endo-112-6-2120. Endocrinology. 1983. PMID: 6343059
-
Effects of porcine intestinal heptacosapeptide and vasoactive intestinal polypeptide on insulin and glucagon secretion in rats.Endocrinology. 1983 Apr;112(4):1469-73. doi: 10.1210/endo-112-4-1469. Endocrinology. 1983. PMID: 6339205
-
Effect of vasoactive intestinal polypeptide on glycogen metabolism in rat hepatocytes.Am J Physiol. 1982 Apr;242(4):E262-72. doi: 10.1152/ajpendo.1982.242.4.E262. Am J Physiol. 1982. PMID: 6801998
-
Effects of gastrointestinal and related hormones on glycogenolysis and gluconeogenesis in cultured liver cells.J Biochem. 1977 Oct;82(4):1073-6. doi: 10.1093/oxfordjournals.jbchem.a131778. J Biochem. 1977. PMID: 924981
-
Effects of vasoactive intestinal peptide on glycogenolysis in cultured liver cells.Endocrinol Jpn. 1979 Apr;26(2):233-7. doi: 10.1507/endocrj1954.26.233. Endocrinol Jpn. 1979. PMID: 477614